A new independent analysis conducted by actuarial firm Milliman reveals that FlyteHealth’s AI-enabled Comprehensive Obesity Care program, piloted in partnership with the State of Connecticut, yielded both high medication adherence and meaningful short-term cost avoidance within its first year.

A Real-World Test: Public Sector, Private Innovation

Faced with surging costs tied to GLP-1 coverage since 2020, Connecticut’s self-insured employee health plan took a bold step in 2023 by launching a pilot with FlyteHealth to better manage obesity treatment for eligible employees and retirees. The results: a projected $1.2 million in pharmaceutical cost avoidance and an 86% adherence rate among new GLP-1 users—figures that far surpass national benchmarks.

In typical commercial settings, just 32% of patients remain on GLP-1 therapy after one year. Worse, only 27% follow their prescribed dosing schedules. These statistics often lead payers to pull back on coverage. But FlyteHealth’s personalized, tech-enabled approach may offer a path forward that makes medical and fiscal sense.

Clinical Expertise Meets AI-Driven Personalization

FlyteHealth’s model blends decades of clinical experience with data intelligence. The care program is rooted in the methodology of obesity medicine expert Dr. Louis Aronne and powered by a patent-pending AI engine that tailors care plans based on individual biometric and behavioral data.

Patients receive virtual care from a multidisciplinary team—physicians, nurse practitioners, and dietitians—alongside medication management, lifestyle coaching, and digital support via wearables and connected devices.

The program’s precision prescribing approach uses BMI-based triage to match patients with the most appropriate treatments, reserving higher-cost medications for those with more severe obesity.

State Leaders Applaud Value-Driven Innovation

“This partnership with FlyteHealth is a clear example of how forward thinking, evidence-based innovation can improve people’s lives while also protecting taxpayer dollars,” said Connecticut State Comptroller Sean Scanlon. “The results show we can deliver high-quality care that’s both clinically effective and fiscally responsible.”

Cheryl Pegus, MD, MPH, FlyteHealth’s executive board chair, echoed that sentiment: “Employers and payers are rightly concerned about costs and access. FlyteHealth is committed to supporting those goals with proven, cost-effective solutions.”

Beyond Cost: Patient Outcomes and Long-Term Potential

While the Milliman study focused solely on pharmaceutical spending, FlyteHealth reports additional health improvements among participants, including:

• A 7.2% reduction in elevated HbA1c
• A 9.4% drop in blood glucose levels
• 13%–16% average weight loss over 12 months

The clinical team also addressed comorbidities such as sleep apnea, steatohepatitis, and cardiovascular disease—highlighting the comprehensive nature of the program.

FlyteHealth CEO Sloan Saunders emphasized that these results demonstrate more than momentary success: “Milliman’s independent analysis validates our model’s ability to achieve patient adherence, optimize resource use, and create meaningful savings. But this is just the start—we’re focused on long-term health and economic impacts.”

Looking Ahead

FlyteHealth plans to evaluate broader medical cost offsets and total cost-of-care reductions in future studies. As demand grows for solutions that bridge innovation with fiscal responsibility, the Connecticut pilot could serve as a national model for scalable, AI-informed obesity and cardiometabolic care.

To access the full Milliman report or learn more, visit www.flytehealth.com.

The post AI-Powered Obesity Care: FlyteHealth Delivers Big Wins for Connecticut’s Public Employees appeared first on Medika Life.

Like an endangered species, preventive medicine and chronic disease management—the US primary care system—face extinction. With nearly 30% of American adults lacking a source of care and 28 percent reporting delaying or not getting care due to cost, the consequences are far-reaching.  The focus on chronic disease prevention and addressing its root causes demands greater attention, as the health of the system—and the people it serves—depends on it. If we are frustrated about something, this is worth the outrage.

It has been almost impossible for elected officials, who too often look for singular villains, to grasp the extent of this system-wide dysfunction. This crisis extends beyond consumer comfort with technology or the cost of medicines. Primary care medicine—the basis for health delivery—is marginalized as an honored medical discipline. Somehow, we opt for a national health system prioritizing sick care over healthcare.

Primary care providers are grappling with burnout and inadequate compensation compared to their specialist counterparts, and the system often prioritizes paperwork over quality of care. Economics drives health delivery and access, and it’s simply not working to the advantage of consumers and primary care physicians.  

Finger-pointing and Senate HELP Committee photo ops cannot solve this nation’s care crisis. What’s needed is a fundamental shift in our approach to illness, prevention, and access—one that addresses the root causes of our failing primary care system and ensures that quality healthcare is accessible to all Americans, regardless of zip code or digital literacy. That will reduce our total health costs.

Obesity and Heart Disease: A Multigenerational Threat

America’s waistline is changing—we are adding notches to the nation’s belts. Obesity rates among younger Americans are climbing, creating an abundance of chronic diseases that once seemed confined to older generations. Alarmingly, heart disease, which had been in decline for decades, is creeping back up.

The invention of new weight-loss drugs like GLP-1 receptor agonists helps many struggling with chronic weight issues and mitigates some health risks. Yet, these drugs are not a complete answer to the challenge. They do not adequately address the underlying risks—heart disease, diabetes, and other chronic conditions—that require ongoing, consistent engagement with health professionals. Without this, even those who benefit from these medications – looking trim – may still end up battling old health challenges.

The persistent challenge of obesity across various age groups in the US, which hovers at +/- 40 percent, reinforces worrisome trends that impact people by age, race and region. A rate stable at 40 percent is not something to celebrate – it requires action. It’s a tipping point for illness.

Prediabetes: A Perfect Public Health Storm

Prediabetes is the nation’s silent epidemic. Close to 90 million adults—more than 1 in 3 Americans—have it, and 90% don’t know they do. Left unchecked, some 20 percent of these people “graduate” to Type 2 diabetes and other complications annually. The rise in obesity among younger populations only exacerbates this issue, setting the stage for an earlier onset of chronic diseases that worsen over time.

Prediabetes demands a dedicated behavior-focused treatment plan. Without significant lifestyle changes, individuals are on a fast track to diabetes and its life-altering complications. And yet, the primary care system—our first line of defense—is buckling under pressure, unable to provide the consistent support patients need. It’s not just the use of medications – it’s understanding that obesity is a multi-system condition and a unique disease that transcends more belt notches.

The Limitations of GLP-1 Drugs:

GLP-1 drugs do reduce weight and lower the risk of diabetes and heart disease. But they are not a substitute for comprehensive care. The underlying dangers—poor cardiovascular health, insulin resistance, and other metabolic issues—don’t disappear with weight loss alone. Without engagement with allied health professionals trained to address the complexities of obesity to monitor and address these risks, consumers will face new challenges despite these drugs’ initial success in losing pounds.

We live in what Katherine Saunders, MD, DABOM, a Weill Cornell Medicine’s Comprehensive Weight Control Center and co-founder of FlyteHealth, calls the “Obese-a-genetic” era.  Her efforts at FlyteHealth leverage the latest in science, technology, patient support, and a range of medications to individually tailor weight treatment based on a person’s unique biology alongside the complexity of obesity treatment:

“Overweight and obesity are misunderstood medical conditions that are more complex than calories in and calories out. The advice many patients receive—to eat less and exercise more—often fails to address the problem.”

Saunders and her colleagues are at the cutting edge of results-oriented care, but she is among the handful who have dedicated their careers to this pressing clinical discipline.

Walk-In Clinics are about Convenience

Convenience of care is essential to people’s well-being. Entrepreneurial internists have recognized this, creating “pop-up” vaccination and care centers to bring services closer to those in need and better work/life balance. But convenience alone isn’t enough. Urgent care clinics underscore one of the nation’s most pressing public health threats—the erosion of primary care—has reached a retail-like inflection point.

Walk-in clinics and telehealth check-ins are helpful but do not offer dedicated follow-up. They are geared to address the consumer’s immediate need and are not structured for the longitudinal engagement for the hard-to-tackle considerations that call for comprehensive support.

We are stuck between a system that focuses on its self-preservation and what is in our and national long-term interests – protecting our most important asset – our health.

The Rise of the Make American Health Again Movement

Primary care physicians, the cornerstone of preventive health, are becoming extinct as a medical profession species. The reasons are many: medical school debt driving doctors to higher-paying specialties, they are paid by the number of patients seen daily burnout, and the rise of retail clinics offering quick, transactional care.

While these clinics improve access, their focus is not on a long-term patient-physician relationship. This shift leaves a dangerous gap in the medical safety net, particularly for chronic conditions like obesity, prediabetes, and heart disease. Without a trusted health provider to guide them, patients are left to navigate their health journeys solo—often with devastating consequences.

Many are aghast at Robert F. Kennedy Jr.’s nomination to the Department of Health and Human Services as Secretary of the nation’s key organization setting national health policy. This justified anxiety centers on his stated positions on vaccines and his off-hand comments dismissing the importance of medicines in preventing more serious illnesses. However, his thoughts about America’s poor health report card grades deserve attention regardless of the outcome of the Senate confirmation hearings.

His Make America Healthy Again movement has an approach that deserves consideration: the need to tackle the chronic disease epidemic, which has become the leading cause of death in the US and, later, drives massive costs in hospitalization.

“There are some things that RFK Jr. gets right,” says Resolve to Save Lives CEO Dr. Tom Frieden, who was appointed Director of the Centers for Disease Control and Prevention during the Obama Administration. “We do have a chronic disease crisis in this country, but we need to avoid simplistic solutions and stick with the science.” Frieden made his comments in an NPR interview on the RFK Jr. nomination.

We need (much) more than medications and pop-up clinics to address America’s growing health crises. The health ecosystem must be reimagined to center around people’s health outcomes – not a one-size-fits-all approach to keeping them well. We must foster long-term patient-provider relationships, ensure easy access to understandable health data, emphasize nutrition and physical education in schools, and make care accessible to people across racial and generational lines.

As the ticking time bombs of obesity, prediabetes, and heart disease continue to warn, the urgency for change cannot be overstated. The frustration over the current complexity of access underscores what happens when we prioritize the system over prevention. Access to care isn’t just a convenience—it’s a matter of survival. To prevent the collapse of this fragile house of cards, we must act decisively and collaboratively to build a health system that sustains us all.

The post Conceptually, the “Make America Healthy Again Movement” Needs a Nod appeared first on Medika Life.